Supply Issues Becton Dickinson Blood Gas Syringe FWC082 (ICN 3462)

• The supply issue with blood gas syringe from Becton Dickinson is continuing.
• One product remains subject to Protect Demand Management:
  • FWC082 – Blood Gas Syringe Without Needle 1ml no needle plus a line slip tip contains 30/50 IU of Spray dried Calcium-balanced Lithium heparin.
• FWC082 is still available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• The supply issue is now anticipated to be resolved by 6 October 2026.

Change:

• The supplier Becton Dickinson UK Ltd Stock Oxford has informed us of a supply issue with its blood gas syringe.
• There is one product code affected:
  • FWC082 – Blood Gas Syringe Without Needle 1ml no needle plus a line slip tip contains 30/50 IU of Spray dried Calcium-balanced Lithium heparin.
• The supply issue is due to increased demand and lead times.
• Due to this ongoing supply issue, this product is now being threshold managed as it is subject to Protect Demand Management.

Impact:

• FWC082 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue:
  • FWC086 – Blood Gas Syringe Without Needle 1ml no needle preset slip tip contains 30/50 IU of Spray dried Calcium-balanced Lithium heparin
  • FWC085 – Blood Gas Syringe Without Needle 3ml no needle plus a line slip tip contains 80/50 IU of Spray dried Calcium-balanced Lithium heparin.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 11 September 2026.

Next Steps:

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and potential alternatives and the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.